![Derek Lindsay](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Derek Lindsay
Algemeen Directeur bij Redx Oncology Ltd.
Profiel
Derek Lindsay is the founder of Redx Pharma Plc, which was founded in 2010.
He held the title of Chief Operating Officer from 2016 to 2017.
Currently, he is the Managing Director at Redx Oncology Ltd., Executive & Finance Director at NHS Ayrshire & Arran, and Chief Operating Officer at AMR Centre Ltd.
In the past, he worked as the Director of Research & Development at Avecia Pharmaceuticals Ltd.
and as the Innovation Director at Britest Ltd.
from 2006 to 2012.
Actieve functies van Derek Lindsay
Bedrijven | Functie | Begin |
---|---|---|
Redx Oncology Ltd.
![]() Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Algemeen Directeur | - |
Infex Therapeutics Ltd.
![]() Infex Therapeutics Ltd. BiotechnologyHealth Technology AMR Centre Ltd. is a British biotechnology research company founded in 2016. The private company is based in Cheshire, UK. The company conducts research in the field of biotechnology. | Operationeel Directeur | - |
Nhs Ayrshire & Arran
![]() Nhs Ayrshire & Arran Hospital/Nursing ManagementHealth Services NHS Ayrshire & Arran is a healthcare provider that offers a wide range of high-quality health services to a population of approximately 367,000 people. NHS Ayrshire & Arran also has a duty to protect public health throughout Ayrshire and Arran. The private company is based in Ayrshire, UK, and has subsidiaries in the United Kingdom. The British company has invested in modern hospitals and community facilities, and its highly trained and qualified staff provide healthcare services. The CEO of the company is Claire Burden. | Financieel Directeur/CFO | 01-04-2000 |
Eerdere bekende functies van Derek Lindsay
Bedrijven | Functie | Einde |
---|---|---|
REDX PHARMA PLC | Oprichter | 31-12-2017 |
Britest Ltd. | Corporate Officer/Principal | 31-12-2012 |
Avecia Pharmaceuticals Ltd.
![]() Avecia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Avecia Pharmaceuticals Ltd. used to manufacture pharmaceutical ingredients. The company was focused on providing custom chemical synthesis and manufacturing services for the pharmaceutical and biotechnology companies. Avecia Pharmaceuticals was headquartered in Manchester, UK | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
REDX PHARMA PLC | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Avecia Pharmaceuticals Ltd.
![]() Avecia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Avecia Pharmaceuticals Ltd. used to manufacture pharmaceutical ingredients. The company was focused on providing custom chemical synthesis and manufacturing services for the pharmaceutical and biotechnology companies. Avecia Pharmaceuticals was headquartered in Manchester, UK | Health Technology |
Britest Ltd. | |
Redx Oncology Ltd.
![]() Redx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Part of Redmile Group LLC, Redx Oncology Ltd. is a British biotech company focused on discovering and developing novel targeted medicines for the treatment of cancer and fibrotic disease. The company is based in Macclesfield, UK, and the CEO of the company is Derek Lindsay. The company's focus is on small molecule inhibitors for fibrotic diseases, with preclinical proof of concept demonstrated in lung and kidney fibrosis models. Redx Pharma recently signed an agreement with Jazz Pharmaceuticals for the potential treatment of raf and ras mutant tumors. | Health Technology |
Nhs Ayrshire & Arran
![]() Nhs Ayrshire & Arran Hospital/Nursing ManagementHealth Services NHS Ayrshire & Arran is a healthcare provider that offers a wide range of high-quality health services to a population of approximately 367,000 people. NHS Ayrshire & Arran also has a duty to protect public health throughout Ayrshire and Arran. The private company is based in Ayrshire, UK, and has subsidiaries in the United Kingdom. The British company has invested in modern hospitals and community facilities, and its highly trained and qualified staff provide healthcare services. The CEO of the company is Claire Burden. | Health Services |
Infex Therapeutics Ltd.
![]() Infex Therapeutics Ltd. BiotechnologyHealth Technology AMR Centre Ltd. is a British biotechnology research company founded in 2016. The private company is based in Cheshire, UK. The company conducts research in the field of biotechnology. | Health Technology |